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The effect of dietary fat intake on hepatic
gene expression in LG/J AND SM/J mice
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Abstract
Background: The liver plays a major role in regulating metabolic homeostasis and is vital for nutrient metabolism.
Identifying the genetic factors regulating these processes could lead to a greater understanding of how liver
function responds to a high-fat diet and how that response may influence susceptibilities to obesity and metabolic
syndrome. In this study we examine differences in hepatic gene expression between the LG/J and SM/J inbred
mouse strains and how gene expression in these strains is affected by high-fat diet. LG/J and SM/J are known to
differ in their responses to a high-fat diet for a variety of obesity- and diabetes-related traits, with the SM/J strain
exhibiting a stronger phenotypic response to diet.
Results: Dietary intake had a significant effect on gene expression in both inbred lines. Genes up-regulated by a
high-fat diet were involved in biological processes such as lipid and carbohydrate metabolism; protein and amino
acid metabolic processes were down regulated on a high-fat diet. A total of 259 unique transcripts exhibited a
significant diet-by-strain interaction. These genes tended to be associated with immune function. In addition,
genes involved in biochemical processes related to non-alcoholic fatty liver disease (NAFLD) manifested different
responses to diet between the two strains. For most of these genes, SM/J had a stronger response to the
high-fat diet than LG/J.
Conclusions: These data show that dietary fat impacts gene expression levels in SM/J relative to LG/J, with SM/J
exhibiting a stronger response. This supports previous data showing that SM/J has a stronger phenotypic response
to high-fat diet. Based upon these findings, we suggest that SM/J and its cross with the LG/J strain provide a good
model for examining non-alcoholic fatty liver disease and its role in metabolic syndrome.
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Background
The relationship between dietary intake and metabolic
syndrome is complex, with a number of genes, genetic
interactions, and gene by environment interactions hav-
ing significant effects on disease susceptibility and sever-
ity. Obesity-related metabolic disorders can occur when
dietary energy intake chronically exceeds expenditure
leading to a variety of conditions that include increased
blood pressure, insulin resistance, and serum cholesterol
levels [1]. Obesity per se is significantly influenced by
both environmental factors, such as diet and exercise,
and genetic factors, with heritability estimates ranging
from 40% to 75% [2,3]. More critically, there is genetic
variation among individuals in their responses to an obe-
sogenic diet, with some being more likely to develop as-
pects of metabolic syndrome than others [4,5].
While metabolism involves a number of different or-
gans, the liver is one of the key organs regulating nutri-
ent homeostasis. Because of its direct involvement in
dietary nutrient metabolism, the liver’s functional associ-
ation to dietary obesity and metabolic syndrome is of
keen interest. Previous work has shown that increased
levels of dietary fat intake are associated with increased
fat deposition in the liver and can lead to non-alcoholic
fatty liver disease (NAFLD) [6-8]. This increase in hep-
atic fat is associated with a higher risk of obesity [9], in-
sulin resistance [10-12], and type 2 diabetes mellitus
[13,14]. As with obesity and metabolic syndrome, it has
been suggested that susceptibility to NAFLD also has a
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strong genetic basis [15-19] with relatively high heritabil-
ity values after controlling for age, sex, race, and body
mass index [17]. Because of the strong association be-
tween hepatic fat accumulation and metabolic syndrome
disorders, understanding how genetic factors influence
the way in which the liver responds to increased dietary
fat levels is critical.
Whole-genome expression studies have previously ex-
amined the effect of dietary fat intake on hepatic gene
expression. A review of these studies shows that many of
the genes whose expression is affected by dietary fat are
related to lipid metabolism, adipocyte differentiation,
defense against foreign bodies or injury, and stress re-
sponse, particularly response to oxidative stress [20]. In
a comprehensive study, Shockley et al. [21] examined
hepatic gene expression profiles in relation to dietary fat
and cholesterol for 10 different inbred mouse strains.
Over all 10 strains, only Gene Ontology (GO) terms for
cholesterol biosynthesis and isoprenoid metabolism were
repressed by a high-fat diet in all of the strains. No bio-
logical GO terms were induced by a high-fat diet across
all strains, indicating that differences in genetic back-
ground have a dominant effect on which genes and
pathways respond to high dietary fat levels. However, the
level of fat in the high-fat diet used by Shockley et al.
[21] was modest (30% calories from fat), the low fat diet
was not matched for other ingredients [22], and the diet-
ary treatment lasted only from 6–10 weeks of age.
This study was designed to evaluate hepatic gene ex-
pression profiles for two mouse strains, LG/J and SM/J,
on both a low and a high-fat diet. While the effect of
dietary intake on hepatic gene expression has been as-
sessed in a number of mouse strains, including SM/J
[21], evaluating differences in expression levels between
SM/J and LG/J provides a unique opportunity to exam-
ine the genetic factors associated with a number of ob-
esity and metabolic syndrome related traits. LG/J and
SM/J mice have been shown to differ in their response
to a high-fat diet for traits involved in various metabolic
syndrome domains [23,24]. SM/J individuals tend to be
more responsive to the effect of a high-fat diet in rela-
tion to body weight, fat depot weight, organ weight,
basal glucose levels, and triglyceride levels [23,24]. In
addition, quantitative trait loci (QTLs) for a number of
these phenotypes, including obesity [25-29], diabetes
[25,30], serum lipid levels [25,31], fatty liver [32] and
multiple domains of metabolic syndrome [33], have been
mapped in populations derived from the intercross of
these two strains. Thus, the goals of this project are two-
fold. First, we describe general differences in gene expres-
sion between these strains, between males and females,
and between animals reared on low- and high-fat diets.
More critically, we identify genes whose response to a
high-fat diet differs between the LG/J and SM/J strains.
Second, we relate these expression differences to genes lo-
cated within previously defined QTLs where genetic ef-
fects were found to be diet-specific.
Results
Global gene expression
Of the 26,209 gene transcripts that showed significant
expression levels, a total of 4,796 unique genes were dif-
ferentially expressed among treatments. Of those, 3,880
transcripts were significantly different between SM/J and
LG/J strains (Additional file 1), 1,224 were significantly
different between males and females (Additional file 2),
and 1,676 transcripts were significantly different by diet
(Additional file 3). Three hundred transcripts showed a
strain by diet interaction, 26 showed a significant strain
by sex interaction, and only two showed a significant
diet-by-sex-by-strain interaction, both of which corre-
sponded to the gene Cidea (Table 1).
Strain Effects. Forty-seven percent of the genes (1,840
gene transcripts) that were significantly different by
strain were expressed more strongly in the LG/J strain
and 53% more strongly in SM/J (2,040 gene transcripts)
(Additional file 1). The genes that were significantly
over-expressed within both LG/J and SM/J strains repre-
sented similar biological processes, such as lipid metab-
olism, protein metabolism and carbohydrate metabolic
processes (Additional file 4). There were, however, differ-
ences in the biochemical pathways these genes repre-
sented (Additional file 4). Biochemical pathways that
contained the largest number of genes over-expressed in
SM/J included several response-to-stimulus pathways,
including the platelet-derived growth factor (PDGF), in-
tegrin, and inflammation by chemokine and cytokine
signaling pathways. In addition, a relatively large number
of genes involved in apoptosis were over-expressed in
SM/J. In LG/J, the metabolic-related pathways that were
enriched included the purine metabolism and the chol-
esterol biosynthesis pathway. Other interesting pathways
over-expressed in LG/J included the endothelin signaling
pathway, the angiogensis pathway, and the insulin/IGF
pathway.
Table 1 Number of differentially expressed genes for
each factor and their interactions
Factor Number of significant genes
Diet 1676
Sex 1224
Strain 3880
Diet*Sex 26
Diet*Strain 300
Sex*Strain 0
Diet*Sex*Strain 2
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Sex Effects. Of the 1,224 expressed transcripts that
were significantly different between males and females,
46% were higher in males (568 gene transcripts) and
54% were higher in females (656 gene transcripts)
(Additional file 2). As expected, genes that are sex-
linked showed significant differences in expression be-
tween the sexes. Inactive X specific transcripts (Xist),
located on the X chromosome, displayed the largest dif-
ferences between males and females. Genes located on
the Y chromosome, such as DEAD box polypeptide 3, Y-
linked (Ddx3y), eukaryotic translation initiation factor 2,
subunit 3, structural gene Y-linked (Eif2s3y) and ubiqui-
tously transcribed tetratricopeptide repeat gene, Y chro-
mosome (Uty), were expressed more in males. A number
of cytochrome p-450 genes (Cyp) were also differentially
expressed between the sexes (Additional file 2). Both
males and females exhibited high expression in genes re-
lated to biological processes, such as lipid metabolism,
Table 2 Biological processes and biochemical pathways enriched by genes exhibiting a diet by strain interaction
GO annotation term GO annotation Mus musculus
genes FEFLIST
(26185)
Number of
genes in
pathway
Number
of genes
expected
Over/
under
represented
P-value
Biological Process
immune system process GO:0002376 2974 62 20.22 + 1.72×10-16
antigen processing and presentation GO:0019882 95 10 0.65 + 1.54×10-9
antigen processing and presentation of
peptide or polysaccharide antigen via
MHC class II
GO:0002504 35 6 0.24 + 1.90×10-7
response to stimulus GO:0050896 2486 52 16.9 + 1.01×10-13
response to stress GO:006950 547 13 3.72 + 1.08×10-4
cellular defense response GO:0006968 564 16 3.83 + 1.93×10-6
response to toxin GO:0009636 121 9 0.82 + 1.92×10-7
signal transduction GO:0007165 4858 52 33.02 + 3.68×10-4
immune response GO:0006955 900 16 6.12 + 4.75×10-4
Unclassified 10946 39 74.41 - 1.81×10-8
metabolic process GO:0008152 9603 93 65.28 + 1.63×10-5
primary metabolic process GO:0044238 9122 91 62.01 + 6.03×10-6
lipid metabolic process GO:0006629 1266 24 8.61 + 6.06×10-6
carbohydrate metabolic process GO:005975 1038 19 7.06 + 9.55×10-5
cellular process GO:0009987 7133 69 48.49 + 5.51×10-4
endocytosis GO:0006897 604 14 4.11 + 7.65×10-5
apoptosis GO:0006915 1035 18 7.04 + 2.73×10-4
developmental process GO:0032502 3296 38 22.41 + 7.37×10-4
system development GO:0048731 2222 29 15.1 + 5.23×10-4
transport GO:0006810 3009 36 20.45 + 5.33×10-4
Biochemical Pathway
Plasminogen activation cascade 18 3 0.12 + 2.74×10-4
p53 pathway 127 5 0.86 + 1.89×10-3
Angiogenesis 193 6 1.31 + 2.22×10-3
Blood coagulation 55 3 0.37 + 6.52×10-3
Integrin signalling pathway 185 5 1.26 + 9.06×10-3
Androgen/estrogene/progesterone biosynthesis 28 2 0.19 + 1.59×10-2
Ornithine degradation 3 1 0.02 + 2.02×10-2
FAS signaling pathway 38 2 0.26 + 2.80×10-2
Methylmalonyl pathway 5 1 0.03 + 3.34×10-2
Xanthine and guanine salvage pathway 6 1 0.04 + 4.00×10-2
p53 pathway feedback loops 2 51 2 0.35 + 4.77×10-2
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carbohydrate metabolism, response to toxin, apoptosis
and the generation of precursor metabolites and energy
(Additional file 5), but the specific genes involved dif-
fered between males and females. On the other hand,
the biochemical pathways represented by genes over-
expressed in females differed substantially from those
up-regulated in males. Pathways with genes expressed
significantly higher in females were typically associated
with amino acid biosynthesis, whereas pathways associ-
ated with increased expression in males were involved in
a number of signaling pathways, including the heterotri-
meric G-protein signaling pathway-Gi alpha and Gs
alpha mediated pathway, the endothelial signaling path-
way, and the cortocotropin releasing factor receptor sig-
naling pathway (Additional file 5).
Response to Diet. For genes that were expressed differ-
ently on high and low-fat diets, 46% were higher in
high-fat fed individuals (775 genes transcripts), while
54% (901 gene transcripts) were higher in low-fat fed in-
dividuals (Additional file 3). GO terms that were
enriched for genes that showed significantly higher ex-
pression in high-fat fed individuals were involved in lipid
and carbohydrate metabolism. Processes enriched in
low-fat fed individuals included those involved in protein
and amino acid metabolic processes (Additional file 6).
Interesting biochemical pathways that were enriched by
genes showing higher expression with high-fat diet are
involved in stress response, such the p53 pathway, integ-
rin signaling pathway, ubiquitin promeasome pathway,
and the inflammation-mediated by chemokine and cyto-
kine signaling pathways. Those enriched with genes that
exhibited higher expression on a low-fat diet included
blood coagulation, EGF receptor signaling, cholesterol
biosynthesis, and a number of amino acid biosynthesis
pathways (Additional file 6).
Diet-by-Strain Interactions. There were 259 genes (300
gene transcripts) whose expression exhibited a significant
diet-by-strain interaction, i.e. diet affected expression dif-
ferently in the two strains (Additional file 7). Gene expres-
sion was much more responsive to the high-fat diet in
SM/J than in LG/J, with 95% of the diet related expression
changes occurring in SM/J. GO terms enriched for genes
exhibiting a diet-by-strain interaction included those in-
volved in immune function, lipid and carbohydrate meta-
bolic processes, and apoptosis (Table 2). The biochemical
pathways that were significantly enriched included the
plasminogen activating pathway, p53 pathway, angiogen-
esis, the integrin signaling pathway, and the blood coagu-
lation pathway (Table 2).
In order to evaluate gene clusters that responded simi-
larly for genes exhibiting a diet-by-strain interaction, a
K-means clustering analysis was preformed and pro-
duced 2 stable gene clusters. Cluster 1 is composed of
genes involved in response to stimulus pathways, such
as the p53 pathway, integrin signaling pathway, and the
TGF signaling pathway (Additional file 8). Cluster two
was comprised of pathways related to multiple salvage
pathways, the plaminogen activating cascade, and blood
coagulation (Additonal file 8). Hierarchical biclustering
of the data also show that high-fat fed SM/J individuals
clustered separately from all other groups for these
genes (Figure 1).
Within Strain Effects. Analyzing SM/J and LG/J separ-
ately for the effects of diet and sex on gene expression
Figure 1 Heat map of genes exhibiting a diet by strain interaction. Hierarchical cluster analysis was performed producing two clusters, with
the high-fat fed SM/J group clustering separately from all other groups. HF-LG: High-fat LG/J; HF-SM: High-fat SM/J; LF-LG: Low-fat LG/J; LF-SM:
Low-fat SM/J.
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produced very different results. When SM/J was ana-
lyzed separately, diet had the strongest effect on gene ex-
pression with 2,137 gene transcripts being differentially
expressed. Of these, 1,200 transcripts were up-regulated
and 937 down-regulated on the high-fat diet (Additional
file 9). Only 25 gene transcripts showed differential ex-
pression in relation to diet in the LG/J strain, 15 with in-
creased expression and 10 with decreased expression on
a high-fat diet (Additional file 9).
The major factor responsible for variation in LG/J gene
expression was sex, with 637 transcripts differentially
expressed between males and females. Of the 637 tran-
scripts, 396 were higher in females and 241 were higher in
males. This is in sharp contrast to the sex effects observed
in SM/J, where only 190 transcripts showed differential
expression (Additional file 10).
Candidate Genes within QTLs
Studies of these strains have previously mapped QTLs af-
fecting obesity, diabetes-related traits, and serum lipid
levels in the LG,SM Advanced Intercross Lines (AIL). We
correlated the list of genes in these QTLs with those dem-
onstrating a differential response between strains to a high
fat diet. Of the 259 genes showing different responses in
LG/J and SM/J in relation to the high fat diet, 18 are lo-
cated within QTLs previously mapped for serum lipid
levels [31], 24 are located within QTLs mapped for obesity
[27], and 20 are located within regions previous associated
with diabetes [30] (Table 3). Chi-square analysis show
QTLs previously identified as associated with serum lipid
levels and obesity were significantly enriched with genes
showing significant diet-by-strain interactions (Obesity:
χ2=5.95, p=0.015; Lipids: χ2=6.91, p=0.008). However,
QTLs associated with diabetes were not enriched
(χ2=1.49; p=0.22). This result indicates that differential
gene expression between strains in response to diet is the
likely source of at least some of the mapped QTL effects.
Discussion
This study has two main goals. The first, to characterize
hepatic gene expression profiles for SM/J and LG/J in-
bred mouse strains and examine how these profiles were
influenced by diet and sex. The second goal is to exam-
ine how expression profiles differ between these two
strains in relation to diet, and to characterize potential
candidate genes located within previously mapped QTLs
that are associated with traits from metabolic syndrome
domains. As expected, our results show that diet, sex,
and strain all have significant impacts on gene expres-
sion, with many genes showing strain-specific dietary re-
sponses for gene expression.
Overall, the impact of the high-fat diet on gene expres-
sion appears to be similar to that found in other expres-
sion studies [20]. There are many more effects than
noted in Shockley et al. [21] perhaps because of the
higher amount of fat in the diet utilized here (42% vs
30%) and the prolongation of the dietary treatment, from
6–10 weeks compared to 3–20 weeks in our study. A
number of defense and stress response pathways were
enriched by genes over-expressed in high-fat fed mice,
including the p53, the inflammation mediated by chemo-
kine and cytokine, and the ubiquitin signaling pathways,
which regulate cellular damage response and influence
inflammatory response. Enrichment of these pathways
supports previous work suggesting that a high-fat diet
can lead to cellular oxidative stress and increased in-
flammation within the liver, potentially resulting in non-
alcoholic steatohepatitis (NASH), liver fibrosis, and
further exacerbating insulin resistance [34-38].
SM/J and LG/J differ in their phenotypic response to a
high-fat diet, with SM/J being more responsive than
LG/J for many obesity, diabetes-related, and serum lipid
level traits [23,24]. While these phenotypic differences
between these strains have previously been observed, the
stark differences in how diet impacts gene expression is
somewhat surprising. A total of 259 unique genes dis-
played significant diet-by-strain interactions. In 95% of
these cases, SM/J mice displayed a greater change in ex-
pression in relation to diet than LG/J mice. Hierarchical
cluster analysis of these genes grouped high-fat fed SM/J
separately from all other groups (Figure 1), again dem-
onstrating that SM/J is more responsive to dietary fat in-
take than LG/J. This suggests that genetic background
plays a significant role in influencing how genes respond
to high-fat diet.
Similar to these results, Shockey et al’s. [21] assess-
ment of how high fat diet affected gene expression
showed that only a few biochemical pathways were com-
monly affected across the strains that were analyzed.
This suggests that there is little consistency between
strains in what is up- or down-regulated on a high fat
diet. This is an important consideration because it
means that genetic background plays a significant role in
how diet impacts gene expression in this system. Thus,
one cannot characterize a general murine response to a
high fat diet for hepatic expression using any specific
strain, such as C57BL/6J. While this may seem like an
obstacle for murine studies of hepatic gene expression, it
also provides a great opportunity to examine how gen-
etic background influences these effects.
The biological processes that are most enriched with
genes showing diet-by-strain interactions were mainly
related to immune system processes, specifically antigen
processing and presentation. Most of the differences
were driven by the effects of the high-fat diet in SM/J
mice. Associated with these are a number of transcripts
involving major histocompatibilty complexes (MHC) I
and II (Hfe, H2-D1, H2-D4, H2-Ea, H2-Ab1, H2-DMa)
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Table 3 Genes transcripts with a significant diet by strain interaction for lipid, obesity, and diabetes QTLs
QTL Probe ID Gene ID Chromosome Start Stop Strand
Lipid Serum QTLs
Dserum1b ILMN_2717387 Fbxo36 1 84836416 84897062 +
Dserum1b ILMN_2502317 Ugt1a10 1 89951963 90115579 +
Dserum1b ILMN_2754718 Ugt1a9 1 89967375 90115572 +
Dserum1c ILMN_2954575 Arhgap30 1 173319085 173340429 +
Dserum3a ILMN_2529128 LOC329702 3 89169322 89178368 +
Dserum3a ILMN_2883392 S100a11 3 93324410 93330209 +
Dserum3a ILMN_1213457 Snx27 3 94301466 94386638 -
Dserum3a ILMN_2837802 BC028528 3 95687877 95695928 -
Dserum3a ILMN_2656422 BC028528 3 95687877 95695928 -
Dserum4a ILMN_2674367 Agrn 4 155539399 155560010 -
Dserum5a ILMN_2690061 Hnrpdl 5 100462596 100468683 -
Dserum8a ILMN_2719473 Asf1b 8 86479406 86494096 +
Dserum10a ILMN_3100812 Gpx4 10 79509911 79519184 +
Dserum10a ILMN_2684855 Gpx4 10 79509911 79519184 +
Dserum17a ILMN_2729447 9030612M13Rik 17 32910210 32924492 -
Dserum17a ILMN_1236993 March2 17 33825041 33855598 -
Dserum17a ILMN_1226525 H2-Ab1 17 34400185 34406355 +
Dserum17a ILMN_2631423 H2-Ab1 17 34400185 34406355 +
Dserum17a ILMN_2913716 H2-Ab1 17 3440185 34406355 +
Dserum17a ILMN_1239102 H2-Eb1 17 34442843 34453144 +
Dserum17a ILMN_2741935 H2-Ea 17 34479878 34481588 -
Dserum17a ILMN_2599858 Pbx2 17 34729416 34734286 +
Dserum18a ILMN_1226868 Mapk4 18 74088140 74225013 -
Dserum19a ILMN_2677859 Insl6 19 29395844 29399808 -
Dserum19a ILMN_2738893 Ermp1 19 29682704 29722905 -
Obesity QTLs
Dob2a ILMN_1220441 Camk1d 2 5214503 5635561 -
Dob3a ILMN_1219717 Sort1 3 108087009 108164429 +
Dob4a ILMN_247997 2310040A07Rik/Enho 4 41585177 41587357 -
Dob6a ILMN_2656021 Osbpl3 6 50243329 50406200 -
Dob6a ILMN_2974064 Osbpl3 6 50243329 50406200 -
Dob6e ILMN_1221060 Pparg 6 115372091 115440419 +
Dob6e ILMN_1216056 2510049J12Rik 6 115533562 115542594 -
Dob6e ILMN_2956092 Rassf4 6 116583026 116623809 -
Dob6e ILMN_2686244 Rassf4 6 116583026 116623809 -
Dob6e ILMN_2672698 Rassf4 6 116583026 116623809 -
Dob8a ILMN_2912598 Ap3m2 8 23897827 23916099 -
Dob8c ILMN_2719473 Asf1b 8 86479406 86494096 +
Dob10b ILMN_1215807 Glipr1 10 111422511 111439687 -
Doc10c ILMN_3162796 Cnot2 10 115922222 116018557 -
Doc10c ILMN_2878071 Lyz 10 116724853 116729924 -
Dob13a ILMN_2865016 Cd83 13 43880572 43898501 +
Dob14a ILMN_2627022 Itih4 14 31699662 31715167 +
Dob14a ILMN_1231336 Itih3 14 31721762 31736731 -
Dob17b ILMN_1236993 March2 17 33825041 33855598 -
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and killer cell activation (Tyrobp, Pira11). In most cases,
there was a significant increase in the expression of these
genes with a high-fat diet in SM/J and either no change or
a slight decrease in expression in LG/J. This suggests a
heightened immune response in SM/J with a high-fat diet,
compared to LG/J mice. There is substantial evidence
suggesting a strong association between immune response
and metabolic function [39]. In particularly, diets that are
high in fat have been shown to trigger immune response,
particularly through inflammation in a number of different
tissues (including adipose and liver) [40-42]. For example,
MHC-II expression tends to increase when cells are under
Table 3 Genes transcripts with a significant diet by strain interaction for lipid, obesity, and diabetes QTLs (Continued)
Dob17b ILMN_1226525 H2-Ab1 17 34400185 34406355 +
Dob17b ILMN_2631423 H2-Ab1 17 34400185 34406355 +
Dob17b ILMN_2913716 H2-Ab1 17 34400185 34406355 +
Dob17b ILMN_1239102 H2-Eb1 17 34442843 34453144 +
Dob17b ILMN_2741935 H2-Ea 17 34479878 34481588 -
Dob17b ILMN_2599858 Pbx2 17 34729416 34734286 +
Dob17b ILMN_2665266 H2-T10 17 36254035 36258389 -
Dob17b ILMN_1230878 H2-T10 17 36254035 36258389 -
Dob17b ILMN_2783997 Trim10 17 37006537 37014750 +
Dob17b ILMN_2426853 Ubd 17 37330873 37332782 +
Dob17b ILMN_2964185 H2-M2 17 37617796 37620474 -
Dob17b ILMN_2742311 Cyp39a1 17 43804474 4388794 +
Dob19a ILMN_1230587 Lpxn 19 12873133 12908301 +
Diabetes QTLs
Ddiab3a ILMN_1222860 381484 3 15848070 15906332 -
Ddiab4a ILMN_2773215 Epb4.1l4b 4 57004844 57156309 -
Ddiab4a ILMN_2775064 Epb4.1l4b 4 57004844 57156309 -
Ddiab4b ILMN_2736168 Ppt1 4 122513485 122536418 +
Ddiab5a ILMN_2424721 Pdgfa 5 139451968 139473324 -
Ddiab6a ILMN_2656021 Ospl3 6 50243329 50406200 -
Ddiab6a ILMN_2974064 Osbpl3 6 50243329 50406200 -
Ddiab5d ILMN_1221060 Pparg 6 115372091 115440419 +
Ddiab5d ILMN_1216056 2510049J12Rik 6 115533562 115542594 -
Ddiab7b ILMN_2658804 Rras 7 52273348 52277016 +
Ddiab7c ILMN_2707494 Mcee 7 71537531 71557007 +
Ddiab8a ILMN_2912598 Ap3m2 8 23897827 23916099 -
Diab8b ILMN_2767918 Ifi30 8 73286673 73290562 -
Diab8b ILMN_1228213 Ifi30 8 73286673 73290562 -
Diab8b ILMN_2749747 Haus8 8 73772460 73796833 -
Ddiab11a ILMN_2727503 Igfbp3 11 7106089 7113900 -
Diab11d ILMN_3147074 Pecam1 11 106515531 106611942 -
Ddiab13a ILMN_2595395 Slc17a2 13 23898862 23917049 +
Ddiab13a ILMN_1217058 Slc17a2 13 23898862 23917049 +
Ddiab13c ILMN_3122081 5133401N09Rik 13 58259015 58266052 +
Ddiab14b ILMN_2627022 Itih4 14 31699662 31715167 +
Ddiab14b ILMN_1231336 Itih3 14 31721762 31736731 -
Diab15b ILMN_2543688 Snord123 15 32170324 32176484
Ddiab16a ILMN_1222821 Rogdi 16 5008823 5013610 -
Ddiab17a ILMN_2933463 Plg 17 12571474 12612250 +
Ddiab19a ILMN_2744398 Ostf1 19 18653818 18706279 -
Transcripts in bold are located just outside the 95% CI for the QTL and were not included in the enrichment analysis.
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oxidative stress [43,44], and increased expression of
MHC-II associated genes in hepatic cells can be induced
by altering levels of dietary cholesterol [45]. Severe oxida-
tive stress can lead to cellular damage, resulting in further
hepatic inflammation, and potentially the development of
heptatic steatosis and insulin resistance [34-38]. The dif-
ference in immune response in relation to diet between
these two strains may, in part, explain why they differ in
their response to dietary treatment. In particular, it pro-
vides some information as to why SM/J mice may show
diminished glucose tolerance in comparison to the LG/J
strain [24] on a high fat diet.
Biochemical pathways that were enriched with genes
showing a diet-by-strain interaction included the plas-
minogen activating pathway, p53 pathway, and angio-
genesis (Table 2). As a consequence of increased hepatic
inflammation and hypoxia, which are associated with
immune response, angiogenesis is commonly induced in
order to increase blood flow and provide oxygen and nu-
trients to damaged areas [46,47]. Interestingly, Liu et al.
[48] found that angiogenesis in a skin wound-healing
model was higher in the MRL strain, which shares 75%
of its DNA identical-by-descent with LG/J, than in other
strains. In our data, we found that diet affected many
genes within this pathway differently and in a strain-
specific fashion. Some genes, including angiopotin (Ang)
and mitogen-activated protein kinase 4 (Mapk4), showed
decreased expression in high-fat fed SM/J mice, Rous
sarcoma oncogene (Src) and Mapk4 showed increased
expression in high-fat fed LG/J mice and the remaining
genes in this pathway with a diet-by-strain effect (i.e.,
platelet derived growth factor (Pdgfa), docking protein 2
(Dok2) and leupaxin (Lpxn)) exhibited increased expres-
sion in high-fat fed SM/J (Table 4). Still, the actual
phenotypic effect that these gene expression changes
have on the liver is unclear. For example, Ang and Pdgfa,
along with other growth factors, have a strong pro-
angiogenic effect when up-regulated [47]. In our data
gene expression levels for Ang were lower in SM/J ani-
mals fed a high-fat diet, while Pdgfa expression levels
significantly increased. Similarly, Lpxn encodes for the
protein leupaxin, a member of the paxillin protein fam-
ily, which play an important role in focal cell adhesion
organization and signal transduction within the extracel-
lular matrix [49,50]. It also provides a platform for SRC
protein binding [50,51]. In our data set Src showed in-
creased expression on a high-fat diet in LG/J, while Lpxn
only showed increased expression in high-fat fed SM/J
animals. It, therefore, appears that while high-fat diet
does impact the angiogenesis pathway for both LG/J and
SM/J, the genes that are impacted differ between the
two. To clarify these results future studies assessing the
effects of high-fat diet on angiogenesis for these strains
should continue. Future studies would also be interest-
ing considering how closely related LG/J is to MRL and
MRL’s strong healing phenotype.
One of the most interesting aspects of this study is
that QTLs associated with many metabolic syndrome
domains, including obesity, diabetes, cholesterol and tri-
glyceride levels, and fatty liver, have previously been
mapped in LG/J by SM/J crosses using the same high
and low-fat diets as used in this study [25,27,30-33].
Thus, by examining how gene expression profiles differ
between these strains, particularly for genes within these
QTL regions, we can narrow the number of positional
candidate genes influencing individual dietary response.
Of the 259 gene transcripts with a significant diet by
strain interaction, 57 were located within previously
mapped QTLs. There was a significant enrichment of
genes for obesity and serum lipid level QTLs, although,
no such enrichment occurred for diabetes-related QTLs.
Several metabolic syndrome components are associated
Table 4 Genes expressing significant diet-by-strain interactions within enriched biochemical pathways
Biochemical pathways Genes within pathway
Plasminogen activating cascade Serpinf2 (↓HFSm), PlgD(↓HFSm), Fga(↓HFSm)
p53 pathway Igfbp3D (↑HFSm), E2f1 (↑HFSm), Ccng1(↑HFSm), Tnfrsf6(↑HFSm), Cdc2a(↑HFSm)
Angiogenesis Src(↑HFLg), Ang(↓HFSm), Mapk4L(↑HFLg, ↓HFSm), Dok2FL(↑HFSm), LpxnMS,Ob(↑HFSm), PdgfaD(↑HFSm)
Blood coagulation Serpinf2(↓HFSm), PlgD(↓HFSm), Fga(↓HFSm)
Integrin signalling pathway Fn1(↑HFLg, ↓HFSm), Src(↑HFLg), RrasD(↑HFSm), Mapk4L(↑HFLg, ↓HFSm), Arl11FL(↑HFSm)
Androgen/estrogene/progesterone biosynthesis Hsd3b4(↓HFLg), Hsd3b2(↓HFSm)
Ornithine degradation Azi2(↓HFSm)
FAS signaling pathway Capg(↑HFSm), Tnfrsf6(↑HFSm)
Methylmalonyl pathway MceeMS,P(↑HFSm)
Xanthine and guanine salvage pathway Hprt1(↑HFSm)
p53 pathway feedback loops 2 E2f1(↑HFSm), Ccng1(↑HFSm)
Arrows indicate wether expression levels were higher or lower in high-fat fed individuals verses low-fat fed individuals. HFSm=High-fat fed SM/J, HFLg=High-fat
fed LG/J. Genes with superscripts are located within and near previously identified QTLs for a number of traits.
DDiabetes QTL, LLipid QTL, FLFatty Liver QTL, MSMetabolic Syndrome QTL, OObesity QTL.
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with genes within and around these regions including per-
oxisome proliferator-activated receptor gamma (Pparg),
energy homeostasis (Enho), insulin-like growth factor
binding protein 3 (Igfbp3), palmitoyl-protein thioesterase
1 (Ppt1), and sortilin 1 (Sort1).
Genes associated with lipid metabolism, such as Pparg
and Enho, were differentially expressed between SM/J and
LG/J strains. Pparg is well known as a major factor involved
in dietary obesity and diabetes [52-54] and one of the major
regulators of adipocyte differentiation. This gene is located
within a QTL affecting both obesity- [27] and diabetes-
related traits [30]. Gene expression profiles for Pparg
showed that high-fat diet increased expression of this gene
in both SM/J and LG/J, although this increase was signifi-
cantly greater in SM/J individuals (Figure 2A). Enho pro-
duces adropin, a protein involved in glucose and lipid
homeostasis [55], and is located within a QTL associated
with obesity [56]. Increased levels of adropin in transgenic
mice were found to be associated with improved response
to diet-induced obesity, insulin resistance, and glucose tol-
erance [54]. In SM/J, the high-fat diet significantly reduces
the expression of Enho, promoting obesity. Expression was
also reduced in high-fat fed LG/J animals, but this decrease
was not as severe as that observed in SM/J (Figure 2B).
Sortilin (Sort1) plays a significant role in the release of
low-density lipoprotein (LDL) cholesterol from the liver to
the blood stream making it a potentially important gene
for NAFLD and is located just outside the 1-LOD drop
support interval of a QTL mapped for obesity [27]. Re-
cently, single nucleotide polymorphisms (SNPs) located in
an enhancer region of this gene have shown to be associ-
ated with an increased risk of myocardial infarction and in-
creased LDL cholesterol levels. In this study, we found that
the overall levels of Sort1 were significantly higher in SM/J
than in LG/J. However, high-fat diet significantly lowered
expression of Sort1 in SM/J, while this effect was not ob-
served for the LG/J strain (Figure 2C). Similarly, total chol-
esterol levels from blood serum tend to be lower in SM/J
compared to LG/J, but these values respond more to diet in
SM/J, with high-fat diet eliciting a significant increase [24].
Genes that have been shown to impact NAFLD were
also differentially expressed between LG/J and SM/J.
Platelet/endothelial cell adhesion molecule 1 (Pecam1) is
a glycoprotein located near a QTL for fatty liver [32]
and diabetes [30]. Previous work has suggested that
Pecam1 is involved in regulating inflammation and
higher expression of this gene protects the liver from the
effect of high dietary fat and NAFLD [57]. High-fat fed
SM/J displayed significantly higher Pecam1 expression
levels when compared to low-fat fed individuals. The ef-
fect of diet on Pecam1 expression was not significant in
LG/J (Figure 2D). This may suggest that the liver in SM/
J mice is under increased stress when fed a high-fat diet
relative to LG/J. Overall, the expression profiles of genes
in QTLs on a high fat diet, support increased obesity,
serum lipid levels, and diabetes associated with the SM/J
alleles.
The only gene transcripts exhibiting a significant 3-
way diet-by-sex-by-strain interaction were for the cell
death-inducing DNA fragmentation factor-alpha (Cidea)
Figure 2 Least square mean intensity values for genes within or near previously identified QTLs that exhibited a diet by strain
interaction. (A) Peroxisome proliferator-activated receptor gamma (Pparg); (B) Energy homeostasis (Enho); (C) Sortilin (Sort1); (D) Platelet/endothelial
cell adhesion molecule 1 (Pecam1). Abbrev: LF-SM: Low-fat SM/J; HF-SM: High-fat SM/J; LF-LG: Low-fat LG/J; HF-LG: High-fat LG/J. Graphs based on LS
mean of raw intensity data. Error bars represent standard error of the mean.
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gene. While this gene is not located within a previously
identified QTL, mice deficient in Cidea do show in-
creased metabolic rates and resistance to obesity when
on a high-fat diet [58]. Cidea expression is strongly asso-
ciated with the production of lipid droplets in white adi-
pose tissue, with increased expression enhancing the size
of the lipid droplets [59]. In addition, this increase is also
associated with increased insulin sensitivity [59]. Cidea
expression is typically regulated by Pparg and our data
show that Cidea and Pparg show similar expression
trends (Figure 3). However, the 3-way interaction of
Pparg was not significant at the whole genome level.
Remaining questions are why such strong differences in
Cidea expression were observed between SM/J males
and SM/J females and whether or not these effects are
also observed in other strains. To our knowledge, there
is no data within the literature addressing sex specific
differences in Cidea expression in relation to diet. Most
studies examining expression levels do not separate out
sex effects, with few exceptions [60], and indeed, for our
data set, the effect observed in SM/J males were strong
enough that when SM/J males and SM/J females were
pooled together a significant increase in Cidea was still
observed. Thus, future studies would benefit from
separating out and examining the sexes individually in
order to determine if significant sex effects are like-
wise occurring.
Conclusions
These data show that dietary fat intake significantly im-
pacts gene expression levels, particularly in SM/J relative
to LG/J. This is consistent with previous phenotypic data
that has shown SM/J to be more responsive than LG/J
to a high-fat diet for metabolic syndrome associated
traits, such as obesity, diabetes and lipid serum levels
[23,24]. Many of the genes that are affected by diet are
related to cellular defense, stress, and inflammation, sug-
gesting that increased dietary fat intake promotes pro-
cesses related to hepatic inflammation more so in SM/J
than in LG/J. As the prevalence of NAFLD and its associ-
ation with obesity and increased risk for metabolic syn-
drome steadily increases among Western societies, it is
becoming vital that we understand the factors that con-
tribute to individual variability in and susceptibility to this
disease. Previous work has shown that genetic differences
between SM/J and LG/J contribute to the amount of fat
that accumulates within the liver on a high-fat diet [32]
and QTLs for this trait have been mapped in recombinant
inbred strains produced from these two parent strains. In
accordance with this and our findings that gene expression
profiles in response to high-fat diet produces a strong in-
flammatory response within the liver, particularly for SM/
J, we suggest that SM/J and its cross with the unresponsive
LG/J strain are a good model for examining non-alcoholic
fatty liver disease and its role in the metabolic syndrome.
Methods
In order to assess the effects of dietary intake on gene ex-
pression in SM/J and LG/J mice, males and females from
each strain were placed on either a low-fat diet (15%, Re-
search Diets #D12284) or high-fat (42%, Harlan-Teklad
#TD88137) diet immediately after weaning (3weeks) until
20 weeks of age (Table 5). Previous work has shown that
SM/J mice consume more calories per gram of body mass
than LG/J; however, there is no difference in the amount
of energy consumed per body mass between individuals
fed a high-fat versus a low-fat diet for either strain [24]. At
20 weeks, mice were sacrificed in late morning after a
four-hour fast and tissue was collected from 4 males and 4
females from each strain and diet. The liver tissue was im-
mediately frozen in liquid nitrogen and stored at −80°C
until extraction. All animal procedures were approved by
Figure 3 Comparison of Cidea and Pparg intensity values.
Abbrev: LF-F: Low-fat female; LF-M: Low-fat male; HF-F: High-fat
female; HF-M: High-fat male. Transformed data are used for
comparison purposes. Error bars represent standard error of
the mean.
Table 5 Components of high-fat and low-fat diets
High fat diet Low fat diet
Energy from fat (%) 42 15
Casein (g/kg) 195 197
Sugars (g/kg) 341 307
Corn starch (g/kg) 150 313
Cellulose (g/kg) 50 50
Corn oil (g/kg) 0 58
Hydrogenated coconut oil (g/kg) 0 7
Anhydrous milk fat (g/kg) 210 0
Cholesterol (g/kg) 1.5 0
Kilojoules per gram 18.95 16.99
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the Washington University in St. Louis Institutional Ani-
mal Care and Use Committee (IACUC).
Total RNA was extracted using RNeasy® 96 Universal
Tissue extraction kits (Qiagen, Valencia, CA) and quantified
using a Nanodrop™ 2000 (Thermo Scientific, Wilmington,
DE). RNA samples were submitted to the Washington Uni-
versity Microarray Core Facility, where quality was as-
sessed using a 2100 Bioanalyzer (Agilent Tecnologies, Palo
Alto, CA). RNA was reverse transcribed and amplified
using an Illumina TotalPrep amplification kit (Ambion,
Austin, TX) and then hybridized onto Illumina® WG-6 v.2
BeadChips (Illumina, San Diego, CA). Arrays were scanned
using the Illumina Beadstation 500. Images were processed
using Illumina BeadScan software and intensity values were
analyzed using Illumina BeadStudio.
Illumina raw data from 45,281 unique probes were read
into R statistical software using the Lumi package [61].
Data were transformed using a variance stabilization
transformation [62], which takes into account the large
number of technical replicates on Illumina arrays, and
normalized using a robust spline normalization. Genes
that showed no significant expression were filtered from
the data set prior to analysis, leaving 26,209 transcripts an-
alyzed for the liver. The data was then read into Partek
Genomics software v. 6.5 (Partek Incorporated, St. Louis,
MO) for further statistical analysis. An ANOVA was used
to examine the impact of diet, strain, sex, and their inter-
actions (diet x strain, diet x sex, sex x strain, and diet x sex
x strain) on differential gene expression. A genome-wide
false discovery rate threshold of 0.05 was used to deter-
mine statistical significance.
K-means and hierarchical clustering analysis were per-
formed in Partek (Partek Incorporated, St. Louis, MO)
on genes that showed significant diet-by-strain interac-
tions (FDR<0.05). K-means clustering was preformed
using a Euclidian distance function with 1,000 iterations
utilizing different values of K. The number of clusters
with the lowest David-Bouldin value was identified as
the most likely value of K. Hierarchical clustering was
performed on group mean data using a Euclidian dis-
tance function and average linkage method.
The Gene Ontology (GO) database PANTHER (http://
pantherdb.org) was used to determine biological processes
and biochemical pathways that were enriched with dif-
ferentially expressed genes. Pathways and processes with
p values<0.05 were considered to be significant.
In order to determine if previously identified QTLs for
diabetes, serum lipid levels, and obesity were signifi-
cantly enriched with genes exhibiting a significant diet-
by-strain interaction, a chi-square test was used to deter-
mine if the number of these genes located within QTLs
significantly differed from what would be expected by
chance. Probability values of <0.05 were used to deter-
mine significance.
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